393
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Protective effect of liver X receptor on cigarette smoke and lipopolysaccharide induced airway inflammation and emphysema in mice

, , , , , , , , & show all
Pages 53-64 | Received 03 Oct 2023, Accepted 06 Mar 2024, Published online: 21 Mar 2024

References

  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Archivos de Bronconeumologia. 2017;53(3):128–149. doi:10.1016/j.arbr.2017.02.001.
  • Pollok J, et al. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease. 2019.
  • Buhl R, Bals R, Baur X, et al. Guideline for the diagnosis and treatment of asthma - guideline of the German Respiratory Society and the German Atemwegsliga in Cooperation with the Paediatric Respiratory Society and the Austrian Society of Pneumology. Pneumologie (Stuttgart, Germany). 2017;71(12):e3.
  • Li Y, Li SY, Li JS, et al. A rat model for stable chronic obstructive pulmonary disease induced by cigarette smoke inhalation and repetitive bacterial infection. Biol Pharm Bull. 2012;35(10):1752–1760. doi:10.1248/bpb.b12-00407.
  • Sethi S. Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon? Proc Am Thorac Soc. 2004;1(2):109–114. doi:10.1513/pats.2306029.
  • Brass DM, Hollingsworth JW, Cinque M, et al. Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis. Am J Respir Cell Mol Biol. 2008;39(5):584–590. doi:10.1165/rcmb.2007-0448OC.
  • Shin NR, Ko JW, Park SH, et al. Protective effect of HwangRyunHaeDok-Tang water extract against chronic obstructive pulmonary disease induced by cigarette smoke and lipopolysaccharide in a mouse model. J Ethnopharmacol. 2017;200:60–65. doi:10.1016/j.jep.2017.02.027.
  • Shin IS, Shin NR, Park JW, et al. Melatonin attenuates neutrophil inflammation and mucus secretion in cigarette smoke-induced chronic obstructive pulmonary diseases via the suppression of Erk-Sp1 signaling. J Pineal Res. 2015;58(1):50–60. doi:10.1111/jpi.12192.
  • Janowski BA, Grogan MJ, Jones SA, et al. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci U S A. 1999;96(1):266–271. doi:10.1073/pnas.96.1.266.
  • Reyes-Quiroz ME, Alba G, Saenz J, et al. Oleic acid modulates mRNA expression of liver X receptor (LXR) and its target genes ABCA1 and SREBP1c in human neutrophils. Eur J Nutr. 2014;53(8):1707–1717. doi:10.1007/s00394-014-0677-0.
  • Endo-Umeda K, Makishima M. Liver X receptors regulate cholesterol metabolism and immunity in hepatic nonparenchymal cells. Int J Mol Sci. 2019;20(20):5045. doi:10.3390/ijms20205045.
  • Ma Z, Deng C, Hu W, et al. Liver X receptors and their agonists: targeting for cholesterol homeostasis and cardiovascular diseases. Curr Issues Mol Biol. 2017;22:41–64. doi:10.21775/cimb.022.041.
  • Hu X, Shen H, Wang Y, et al. Liver X receptor agonist TO901317 attenuates paraquat-induced acute lung injury through inhibition of NF-κB and JNK/p38 MAPK signal pathways. Biomed Res Int. 2017;2017:4652695–4652613. doi:10.1155/2017/4652695.
  • Cheng Q, Fang L, Feng D, et al. Memantine ameliorates pulmonary inflammation in a mice model of COPD induced by cigarette smoke combined with LPS. Biomed Pharmacother. 2019;109:2005–2013. doi:10.1016/j.biopha.2018.11.002.
  • Liu R, Wang P, Wu C, et al. Therapeutic effects of Hedyotis diffusa Willd in a COPD mouse model challenged with LPS and smoke. Exp Therap Med. 2018;15(4):3385–3391.
  • Shin NR, Kim SH, Ko JW, et al. HemoHIM, a herbal preparation, alleviates airway inflammation caused by cigarette smoke and lipopolysaccharide. Lab Anim Res. 2017;33(1):40–47. doi:10.5625/lar.2017.33.1.40.
  • Voynow JA, Fischer BM, Malarkey DE, et al. Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol Lung Cell Mol Physiol. 2004;287(6):L1293–1302. doi:10.1152/ajplung.00140.2004.
  • Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 1998;53(2):129–136. doi:10.1136/thx.53.2.129.
  • Fournier M, Lebargy F, Le Roy Ladurie F, et al. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis. 1989;140(3):737–742. doi:10.1164/ajrccm/140.3.737.
  • Saetta M, Turato G, Facchini FM, et al. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med. 1997;156(5):1633–1639. doi:10.1164/ajrccm.156.5.9701081.
  • Wang L, Pelgrim CE, Swart DH, et al. SUL-151 Decreases airway neutrophilia as a prophylactic and therapeutic treatment in mice after cigarette smoke exposure. Int J Mol Sci. 2021;22(9)doi:10.3390/ijms22094991.
  • Yu X, Seow HJ, Wang H, et al. Matrine reduces cigarette smoke-induced airway neutrophilic inflammation by enhancing neutrophil apoptosis. Clin Sci (Lond). 2019;133(4):551–564. doi:10.1042/CS20180912.
  • Sonett J, Goldklang M, Sklepkiewicz P, et al. A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure. Faseb J. 2018;32(12):fj201701381–6736. doi:10.1096/fj.201701381.
  • Zhu C, Di D, Zhang X, et al. TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells. Lipids Health Dis. 2011;10(1):199. doi:10.1186/1476-511X-10-199.
  • Houck KA, Borchert KM, Hepler CD, et al. T0901317 is a dual LXR/FXR agonist. Mol Genet Metab. 2004;83(1-2):184–187. doi:10.1016/j.ymgme.2004.07.007.
  • Mitro N, Vargas L, Romeo R, et al. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett. 2007;581(9):1721–1726. doi:10.1016/j.febslet.2007.03.047.
  • Degraaf AJ, Zasłona Z, Bourdonnay E, et al. Prostaglandin E2 reduces Toll-like receptor 4 expression in alveolar macrophages by inhibition of translation. Am J Respir Cell Mol Biol. 2014;51(2):242–250. doi:10.1165/rcmb.2013-0495OC.
  • Kirby AC, Raynes JG, Kaye PM. CD11b regulates recruitment of alveolar macrophages but not pulmonary dendritic cells after pneumococcal challenge. J Infect Dis. 2006;193(2):205–213. doi:10.1086/498874.
  • Jubinville É, Routhier J, Maranda-Robitaille M, et al. Pharmacological activation of liver X receptor during cigarette smoke exposure adversely affects alveolar macrophages and pulmonary surfactant homeostasis. Am J Physiol Lung Cell Mol Physiol. 2019;316(4):L669–l678. doi:10.1152/ajplung.00482.2018.
  • Ou G, Zhu M, Huang Y, et al. HSP60 regulates the cigarette smoke-induced activation of TLR4-NF-κB-MyD88 signalling pathway and NLRP3 inflammasome. Int Immunopharmacol. 2022;103:108445. doi:10.1016/j.intimp.2021.108445.
  • Wang Y, Wang Y, Ma J, et al. YuPingFengSan ameliorates LPS-induced acute lung injury and gut barrier dysfunction in mice. J Ethnopharmacol. 2023;312:116452. doi:10.1016/j.jep.2023.116452.
  • Ju J, Li Z, Shi Q. Baicalin inhibits inflammation in rats with chronic obstructive pulmonary disease by the TLR2/MYD88/NF-κBp65 signaling pathway. Evid Based Complement Alternat Med. 2022;2022:7273387–7273311. doi:10.1155/2022/7273387.
  • Yanagibashi T, Nagai Y, Watanabe Y, et al. Differential requirements of MyD88 and TRIF pathways in TLR4-mediated immune responses in murine B cells. Immunol Lett. 2015;163(1):22–31. doi:10.1016/j.imlet.2014.11.012.
  • Putra AB, Nishi K, Shiraishi R, et al. Jellyfish collagen stimulates production of TNF-α and IL-6 by J774.1 cells through activation of NF-κB and JNK via TLR4 signaling pathway. Mol Immunol. 2014;58(1):32–37. doi:10.1016/j.molimm.2013.11.003.
  • Sakai J, Cammarota E, Wright JA, et al. Lipopolysaccharide-induced NF-κB nuclear translocation is primarily dependent on MyD88, but TNFα expression requires TRIF and MyD88. Sci Rep. 2017;7(1):1428. doi:10.1038/s41598-017-01600-y.
  • Morissette MC, Shen P, Thayaparan D, et al. Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice. Eur Respir J. 2015;46(5):1451–1460. doi:10.1183/09031936.00216914.
  • Mo J, Fang SJ, Chen W, et al. Regulation of ALK-1 signaling by the nuclear receptor LXRbeta. J Biol Chem. 2002;277(52):50788–50794. doi:10.1074/jbc.M210376200.
  • Cannon MV, Yu H, Candido WM, et al. The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects. Eur J Heart Fail. 2015;17(3):273–282. doi:10.1002/ejhf.243.
  • Delvecchio CJ, Bilan P, Radford K, et al. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells. Mol Endocrinol. 2007;21(6):1324–1334. doi:10.1210/me.2007-0017.
  • Zhang J, Wu Z, Yu F, et al. Role of liver-X-receptors in airway remodeling in mice with chronic allergic asthma. Exp Ther Med. 2021;22(3):920. doi:10.3892/etm.2021.10352.
  • Zhang H, Li X, Qian Z. Regulation of macrophage cholesterol efflux and liver X receptor α activation by nicotine. Int J Clin Exp Med. 2015;8(9):16374–16378.
  • Vale K. Targeting the JAK-STAT pathway in the treatment of ‘Th2-high’ severe asthma. Future Med Chem. 2016;8(4):405–419. doi:10.4155/fmc.16.4.
  • Pernis AB, Rothman PB. JAK-STAT signaling in asthma. J Clin Invest. 2002;109(10):1279–1283. doi:10.1172/JCI0215786.
  • Kim SY, Lim EJ, Yoon YS, et al. Liver X receptor and STAT1 cooperate downstream of Gas6/Mer to induce anti-inflammatory arginase 2 expression in macrophages. Sci Rep. 2016;6(1):29673. doi:10.1038/srep29673.
  • Higham A, Lea S, Plumb J, et al. The role of the liver X receptor in chronic obstructive pulmonary disease. Respir Res. 2013;14(1):106. doi:10.1186/1465-9921-14-106.
  • Shi Y, Xu X, Tan Y, et al. A liver-X-receptor ligand, T0901317, attenuates IgE production and airway remodeling in chronic asthma model of mice. PLoS One. 2014;9(3):e92668. doi:10.1371/journal.pone.0092668.